Report Detail

Pharma & Healthcare Global Preclinical CRO Market Insights, Forecast to 2025

  • RnM2451702
  • |
  • 31 May, 2019
  • |
  • Global
  • |
  • 117 Pages
  • |
  • QYResearch
  • |
  • Pharma & Healthcare

A preclinical CRO treatment is likely to offer the knowledge, experience, and skill needed to take a pharmaceutical medical device or product from the drawing board to distribution. The preclinical contract research organizations (CRO) sector has witnessed a period of tremendous development in the past, profiting from quickly growing (R&D) spending. Several pharmaceutical companies have lost revenue owing to growing patent expirations thus encouraging several manufacturers to outsource factors of the drug manufacturing method to CROs to decrease costs. Due to this, CROs are witnessing significant development.
The global Preclinical CRO market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Preclinical CRO market based on company, product type, end user and key regions.

This report studies the global market size of Preclinical CRO in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Preclinical CRO in these regions.
This research report categorizes the global Preclinical CRO market by top players/brands, region, type and end user. This report also studies the global Preclinical CRO market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Charles River Laboratories
Laboratory Corporation of America
Envigo
Eurofins Scientific
PRA Health Science
Wuxi AppTec
Medpace
Pharmaceutical Product Development
Paraxel

Market size by Product
Bioanalysis and DMPK Studies
Toxicology Testing
Others
Market size by End User
Biopharmaceutical Companies
Government and Academic Institutes
Medical Device Companies

Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa

The study objectives of this report are:
To study and analyze the global Preclinical CRO market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Preclinical CRO market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Preclinical CRO companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Preclinical CRO submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Preclinical CRO are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Preclinical CRO market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.


Table of Contents

    1 Study Coverage

    • 1.1 Preclinical CRO Product
    • 1.2 Market Segments
    • 1.3 Key Manufacturers Covered
    • 1.4 Market by Type
      • 1.4.1 Global Preclinical CRO Market Size Growth Rate by Product
      • 1.4.2 Bioanalysis and DMPK Studies
      • 1.4.3 Toxicology Testing
      • 1.4.4 Others
    • 1.5 Market by End User
      • 1.5.1 Global Preclinical CRO Market Size Growth Rate by End User
      • 1.5.2 Biopharmaceutical Companies
      • 1.5.3 Government and Academic Institutes
      • 1.5.4 Medical Device Companies
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Executive Summary

    • 2.1 Global Preclinical CRO Market Size
      • 2.1.1 Global Preclinical CRO Revenue 2014-2025
      • 2.1.2 Global Preclinical CRO Sales 2014-2025
    • 2.2 Preclinical CRO Growth Rate by Regions
      • 2.2.1 Global Preclinical CRO Sales by Regions
      • 2.2.2 Global Preclinical CRO Revenue by Regions

    3 Breakdown Data by Manufacturers

    • 3.1 Preclinical CRO Sales by Manufacturers
      • 3.1.1 Preclinical CRO Sales by Manufacturers
      • 3.1.2 Preclinical CRO Sales Market Share by Manufacturers
      • 3.1.3 Global Preclinical CRO Market Concentration Ratio (CR5 and HHI)
    • 3.2 Preclinical CRO Revenue by Manufacturers
      • 3.2.1 Preclinical CRO Revenue by Manufacturers (2014-2019)
      • 3.2.2 Preclinical CRO Revenue Share by Manufacturers (2014-2019)
    • 3.3 Preclinical CRO Price by Manufacturers
    • 3.4 Preclinical CRO Manufacturing Base Distribution, Product Types
      • 3.4.1 Preclinical CRO Manufacturers Manufacturing Base Distribution, Headquarters
      • 3.4.2 Manufacturers Preclinical CRO Product Type
      • 3.4.3 Date of International Manufacturers Enter into Preclinical CRO Market
    • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Product

    • 4.1 Global Preclinical CRO Sales by Product
    • 4.2 Global Preclinical CRO Revenue by Product
    • 4.3 Preclinical CRO Price by Product

    5 Breakdown Data by End User

    • 5.1 Overview
    • 5.2 Global Preclinical CRO Breakdown Data by End User

    6 North America

    • 6.1 North America Preclinical CRO by Countries
      • 6.1.1 North America Preclinical CRO Sales by Countries
      • 6.1.2 North America Preclinical CRO Revenue by Countries
      • 6.1.3 United States
      • 6.1.4 Canada
      • 6.1.5 Mexico
    • 6.2 North America Preclinical CRO by Product
    • 6.3 North America Preclinical CRO by End User

    7 Europe

    • 7.1 Europe Preclinical CRO by Countries
      • 7.1.1 Europe Preclinical CRO Sales by Countries
      • 7.1.2 Europe Preclinical CRO Revenue by Countries
      • 7.1.3 Germany
      • 7.1.4 France
      • 7.1.5 UK
      • 7.1.6 Italy
      • 7.1.7 Russia
    • 7.2 Europe Preclinical CRO by Product
    • 7.3 Europe Preclinical CRO by End User

    8 Asia Pacific

    • 8.1 Asia Pacific Preclinical CRO by Countries
      • 8.1.1 Asia Pacific Preclinical CRO Sales by Countries
      • 8.1.2 Asia Pacific Preclinical CRO Revenue by Countries
      • 8.1.3 China
      • 8.1.4 Japan
      • 8.1.5 Korea
      • 8.1.6 India
      • 8.1.7 Australia
      • 8.1.8 Indonesia
      • 8.1.9 Malaysia
      • 8.1.10 Philippines
      • 8.1.11 Thailand
      • 8.1.12 Vietnam
      • 8.1.13 Singapore
    • 8.2 Asia Pacific Preclinical CRO by Product
    • 8.3 Asia Pacific Preclinical CRO by End User

    9 Central & South America

    • 9.1 Central & South America Preclinical CRO by Countries
      • 9.1.1 Central & South America Preclinical CRO Sales by Countries
      • 9.1.2 Central & South America Preclinical CRO Revenue by Countries
      • 9.1.3 Brazil
    • 9.2 Central & South America Preclinical CRO by Product
    • 9.3 Central & South America Preclinical CRO by End User

    10 Middle East and Africa

    • 10.1 Middle East and Africa Preclinical CRO by Countries
      • 10.1.1 Middle East and Africa Preclinical CRO Sales by Countries
      • 10.1.2 Middle East and Africa Preclinical CRO Revenue by Countries
      • 10.1.3 GCC Countries
      • 10.1.4 Turkey
      • 10.1.5 Egypt
      • 10.1.6 South Africa
    • 10.2 Middle East and Africa Preclinical CRO by Product
    • 10.3 Middle East and Africa Preclinical CRO by End User

    11 Company Profiles

    • 11.1 Charles River Laboratories
      • 11.1.1 Charles River Laboratories Company Details
      • 11.1.2 Company Business Overview
      • 11.1.3 Charles River Laboratories Preclinical CRO Sales, Revenue and Gross Margin (2014-2019)
      • 11.1.4 Charles River Laboratories Preclinical CRO Products Offered
      • 11.1.5 Charles River Laboratories Recent Development
    • 11.2 Laboratory Corporation of America
      • 11.2.1 Laboratory Corporation of America Company Details
      • 11.2.2 Company Business Overview
      • 11.2.3 Laboratory Corporation of America Preclinical CRO Sales, Revenue and Gross Margin (2014-2019)
      • 11.2.4 Laboratory Corporation of America Preclinical CRO Products Offered
      • 11.2.5 Laboratory Corporation of America Recent Development
    • 11.3 Envigo
      • 11.3.1 Envigo Company Details
      • 11.3.2 Company Business Overview
      • 11.3.3 Envigo Preclinical CRO Sales, Revenue and Gross Margin (2014-2019)
      • 11.3.4 Envigo Preclinical CRO Products Offered
      • 11.3.5 Envigo Recent Development
    • 11.4 Eurofins Scientific
      • 11.4.1 Eurofins Scientific Company Details
      • 11.4.2 Company Business Overview
      • 11.4.3 Eurofins Scientific Preclinical CRO Sales, Revenue and Gross Margin (2014-2019)
      • 11.4.4 Eurofins Scientific Preclinical CRO Products Offered
      • 11.4.5 Eurofins Scientific Recent Development
    • 11.5 PRA Health Science
      • 11.5.1 PRA Health Science Company Details
      • 11.5.2 Company Business Overview
      • 11.5.3 PRA Health Science Preclinical CRO Sales, Revenue and Gross Margin (2014-2019)
      • 11.5.4 PRA Health Science Preclinical CRO Products Offered
      • 11.5.5 PRA Health Science Recent Development
    • 11.6 Wuxi AppTec
      • 11.6.1 Wuxi AppTec Company Details
      • 11.6.2 Company Business Overview
      • 11.6.3 Wuxi AppTec Preclinical CRO Sales, Revenue and Gross Margin (2014-2019)
      • 11.6.4 Wuxi AppTec Preclinical CRO Products Offered
      • 11.6.5 Wuxi AppTec Recent Development
    • 11.7 Medpace
      • 11.7.1 Medpace Company Details
      • 11.7.2 Company Business Overview
      • 11.7.3 Medpace Preclinical CRO Sales, Revenue and Gross Margin (2014-2019)
      • 11.7.4 Medpace Preclinical CRO Products Offered
      • 11.7.5 Medpace Recent Development
    • 11.8 Pharmaceutical Product Development
      • 11.8.1 Pharmaceutical Product Development Company Details
      • 11.8.2 Company Business Overview
      • 11.8.3 Pharmaceutical Product Development Preclinical CRO Sales, Revenue and Gross Margin (2014-2019)
      • 11.8.4 Pharmaceutical Product Development Preclinical CRO Products Offered
      • 11.8.5 Pharmaceutical Product Development Recent Development
    • 11.9 Paraxel
      • 11.9.1 Paraxel Company Details
      • 11.9.2 Company Business Overview
      • 11.9.3 Paraxel Preclinical CRO Sales, Revenue and Gross Margin (2014-2019)
      • 11.9.4 Paraxel Preclinical CRO Products Offered
      • 11.9.5 Paraxel Recent Development

    12 Future Forecast

    • 12.1 Preclinical CRO Market Forecast by Regions
      • 12.1.1 Global Preclinical CRO Sales Forecast by Regions 2019-2025
      • 12.1.2 Global Preclinical CRO Revenue Forecast by Regions 2019-2025
    • 12.2 Preclinical CRO Market Forecast by Product
      • 12.2.1 Global Preclinical CRO Sales Forecast by Product 2019-2025
      • 12.2.2 Global Preclinical CRO Revenue Forecast by Product 2019-2025
    • 12.3 Preclinical CRO Market Forecast by End User
    • 12.4 North America Preclinical CRO Forecast
    • 12.5 Europe Preclinical CRO Forecast
    • 12.6 Asia Pacific Preclinical CRO Forecast
    • 12.7 Central & South America Preclinical CRO Forecast
    • 12.8 Middle East and Africa Preclinical CRO Forecast

    13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

    • 13.1 Market Opportunities and Drivers
    • 13.2 Market Challenges
    • 13.3 Market Risks/Restraints
    • 13.4 Macroscopic Indicators

    14 Value Chain and Sales Channels Analysis

    • 14.1 Value Chain Analysis
    • 14.2 Preclinical CRO Customers
    • 14.3 Sales Channels Analysis
      • 14.3.1 Sales Channels
      • 14.3.2 Distributors

    15 Research Findings and Conclusion

      16 Appendix

      • 16.1 Research Methodology
        • 16.1.1 Methodology/Research Approach
        • 16.1.2 Data Source
      • 16.2 Author Details

      Summary:
      Get latest Market Research Reports on Preclinical CRO . Industry analysis & Market Report on Preclinical CRO is a syndicated market report, published as Global Preclinical CRO Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of Preclinical CRO market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

      Last updated on

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $3,900.00
      $5,850.00
      $7,800.00
      3,116.10
      4,674.15
      6,232.20
      3,650.40
      5,475.60
      7,300.80
      613,782.00
      920,673.00
      1,227,564.00
      325,611.00
      488,416.50
      651,222.00
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report